Presentation is loading. Please wait.

Presentation is loading. Please wait.

Supplemental testing methods

Similar presentations


Presentation on theme: "Supplemental testing methods"— Presentation transcript:

1 Supplemental testing methods
Screening agar Agar contains known conc. of antibiotic Growth on agar indicates resistance Oxacillin screening agar: 6 g/ml oxacillin Screening of staphylococci Vancomycin screening agar: 6 g/ml vanco Screening of enterococci and staphylococci Certain resistance mechanisms may be difficult to detect

2 This is an example of oxacillin agar
This is an example of oxacillin agar. It is used to verify results from automated testing for methicillin resistance (MRSA) of Staph.aureus. If the plate and the automated results don’t match the specimen must be retested and no results can be given out. There is another plate used to verify vancomycin resistance for enterococcus species.

3 Supplemental testing methods
Predictor drugs Staphylococci R to Oxacillin = R to penicillins, cephalosporins, and imipenem High level gentimicin R in enterococci = R to all currently available aminoglycosides Ampicillin R in enterococci = R to all penicillin derivatives and imipenem

4 Direct detection of resistance mechanisms
Beta-lactamase (phenotypic) Chromogenic substrate incorporated into disk - color change in presence of enzyme Usefulness is limited: Penicillin R in Neisseria gonorrhea Ampicillin R in Haemophilus influenzae Penicillin R in anaerobes This refers to one of the spot tests that we looked at. The disk looks similar to an antibiotic testing disk but it has the chromogenic substrate impregnated into the disk and the bacterial colony is smeared across it, if positive there is a dark reddish color change.

5 Direct detection of resistance mechanisms
Extended spectrum beta-lactamase Mutations in plasmid-encoded beta-lactamases - hydrolyze extended spectrum cephalosporins and aztreonam - more than 100 types have been identified - isolates are often resistant to other classes Interpretive criteria available for: - E. coli, K. pneumoniae, K. oxytoca, P. mirabilis Patients found to have any of the resistance mechanisms for MRSA, VRE, ESBL or other multi-drug resistant strains must be place in contact isolation immediately to help prevent the spread of resistance.

6 Direct detection of resistance mechanisms
Extended spectrum beta-lactamase Screen with aztreonam or cefpodoxime R = requires confirmatory testing Confirmatory testing: Ceftazidime v. ceftaz + clavulanic acid Cefotaxime v. cefotax + clavulanic acid KB: >/= 5 mm increase w/ BLI MIC: >/= 3-fold decr in MIC w/ BLI

7 With clavulanic acid Without clavulanic acid
                                                                                     Note the large difference in zone size between the two disks, the zone size has an increase of 5 mm or greater when clavulanic acid is added. This is what we would see if the bacteria was ESBL. Without clavulanic acid

8 Direct detection of resistance mechanisms
Oxacillin R due to PBP2a (phenotypic) Latex agglutination test to detect altered PBP in staphylococci Presence confers resistance to Oxacillin Depends on expression of protein

9 Direct detection of resistance mechanisms
Oxacillin R due to PBP2a (genotypic) PCR to detect mecA gene in staphylococci Positive not dependent on expression, a positive result simply indicates presence

10 Direct detection of resistance mechanisms
Inducible clindamycin resistance (D test) Resistance to macrolides can occur through: efflux (msrA) ribosome alteration (erm) Erythro R msrA or inducible erm Clinda S Erythro R constitutive erm Clinda R

11 L: Erythro, R: Clinda No resistance Efflux Constitutive erm
Inducible erm

12 Laboratory strategies for testing
Goals of effective strategies include: Relevance Accuracy Communication

13 Laboratory strategies for testing
Criteria used for assessing relevance: Clinical significance of isolate Predictability of susceptibility against drugs of choice Availability of reliable standardized methods Selection of appropriate agents

14 Laboratory strategies for testing
Clinical significance Abundance in direct smear Ability to cause disease in that body site Colonizer or pathogen? Body site of isolation Again, the microbiologist must know the source of the specimen to reliably report antibiotic susceptibilities. Some drugs are not affective for some body sites.

15 Laboratory strategies for testing
Predictability of susceptibility Testing not required when susceptibility is predictable Pen S in beta-hemolytic streptococci Ceph S in GC Clinical requirements can result in exceptions For example: physicians can treat strep throat without having done a susceptibility panel because Group A strep is considered universally susceptible to the penicillin family.

16 Laboratory strategies for testing
Availability of standardized methods Testing cannot be performed if standardized method does not exist Method and interpretive guidelines required – CLSI guide Info available for most pathogenic bacteria Fungi, Nocardia, AFB (Mycobacterium)

17 Laboratory strategies for testing
Selection of agents Previously discussed criteria: Organism ID or group Acquired resistance patterns Testing method used Site of infection Formulary

18 Laboratory strategies for testing
Communication Prompt and thorough review of results Prompt resolution of unusual results Augment susceptibility reports with messages that help clarify and explain potential therapeutic problems not necessarily evident by data alone The microbiology department works very closely with the infectious disease doctors and the pharmacy. There is constant (daily) communication about the prevalence and resistance patterns currently being seen at the hospital (or other facility).

19 Antibiograms: The hospital antibiogram is a periodic summary of antimicrobial susceptibilities of local bacterial isolates submitted to the hospital's clinical microbiology laboratory. Antibiograms are often used by clinicians to assess local susceptibility rates, as an aid in selecting empiric antibiotic therapy, and in monitoring resistance trends over time within an institution.

20 Antibiograms: Antibiograms can also used to compare susceptibility rates across institutions and track resistance trends. These trends can then be used to develop the appropriate formulary for the hospital.

21 Here’s an example of an antibiogram.


Download ppt "Supplemental testing methods"

Similar presentations


Ads by Google